Browse > Article

The Clinical Significance of Soluble Intercellular Adhesion Molecule-1 sICAM-1) and Soluble Vascular Cell Adhesion Molecule-1(sVCAM-1) in Kawasaki Disease  

Rhee, Kang Won (Department of Pediatrics, College of Medicine, Chung-Ang University)
Yun, Sin Weon (Department of Pediatrics, College of Medicine, Chung-Ang University)
Lee, Dong Keun (Department of Pediatrics, College of Medicine, Chung-Ang University)
Choi, Eung Sang (Department of Pediatrics, College of Medicine, Chung-Ang University)
Yoo, Byeong Hoon (Department of Pediatrics, College of Medicine, Chung-Ang University)
Lee, Mi Kyung (Department of Laboratory Medicine, College of Medicine, Chung-Ang University)
Publication Information
Clinical and Experimental Pediatrics / v.48, no.6, 2005 , pp. 640-648 More about this Journal
Abstract
Purpose : Kawasaki disease(KD) is known as an acute multi-systemic vasculitis with various immunologic abnormalities. Adhesion of leukocyte to endothelial cells is a key event in the sequence of inflammatory response. This study was performed to investigate the clinical significance of serum soluble intercellular adhesion molecule-1(sICAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) in acute and subacute stages of typical KD for diagnostic and prognostic value. Methods : A typical KD group was 32 patients who were hospitalized from Jan. 2002 to Jun. 2004 was enrolled. Control was 16 non-KD patients with febrile illness. sICAM-1 and sVCAM-1 were measured and compared by Echocardiographic and clinical findings and cardiac troponin T and I. Results : sICAM-1 and sVCAM-1 levels of acute KD were significantly elevated over control(P=0.019 vs. P=0.049, respectively) and sICAM-1 was significantly decreased in subacute stage(P=0.0015). sICAM-1 and sVCAM-1 had positive correlation with each other in both stages(P=0.0067, P=0.015, retrospectively). Neither sICAM-1 nor sVCAM-1 correctly reflected the coronary abnormalities and responsiveness to intravenous gammaglobulin(IVGG) in both stages. But sVCAM-1 was significantly increased in the carditis group in both stages(P=0.025, P=0.014, retrospectively) and had a positive correlation with troponin T(r=0.63, P=0.00063). Conclusion : The levels of sICAM-1 and sVCAM-1 were not very useful tools for detecting and predicting subsequent coronary abnormalities and responsiveness to IVGG in KD patients. However, sVCAM-1 appears to play a significant role in carditis of KD. Further studies are needed about various adhesion molecules and cytokines in the pathogenesis of KD.
Keywords
Kawasaki disease; ICAM-1; VCAM-1; Coronary disease; Carditis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of fingers and toes. Arerugi 1967;16:178-222
2 Leung DYM, Geha RS, Newburger JW, Burns JC, Fiers W, Lapierre LA, et al. Two monokines, interferon-1 and tumor necrosis factor, render cultured vascular endotherial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med 1986;164:1958-72   DOI   ScienceOn
3 Shimizu Y, Newman W, Shaw S. Lymphocyte interactions with endothelial cells. Immunol Today 1992;13:106-12   DOI   ScienceOn
4 Faruqi RM, DiCorleto PE. Mechanisms of monocyte recruitment and accumulation. Br Heart J 1993;69(1 Suppl):19S-29S   DOI
5 Lasky LA. Selectins : Interpreters of cell-specific carbohydrate information during inflammation. Science 1992;258:964-9   DOI   PUBMED
6 Yun SW. Diagnostic value of serum cardiac troponin T, troponin I and CK-MB in acute Kawasaki disease. Korean Circ J 2004;34:82-92
7 Park YW, Park IS, Kim CH, Ma JS, Lee SB, Kim CH, et al. Update of an epidemiologic study of Kawasaki disease in Korea, comparing with the results of 1991-96 survey. Program and Abstract, the 51st Annual Fall Meeting of the Korean Pediatric Society; 2001 Oct 19-20; Seoul. Seoul :The Korean Pediatric Society, 2001:83
8 Bereta J, Bereta M, Allison AC, Kruger PB, Koj A. Inhibitory effect of di-catechol rooperol on VCAM-1 and iNOS expression in cytokine-stimulated endothelium. Life Sci 1997;60:325-34
9 Takeshita S, Dobashi H, Nakatani K, Koike Y, Tsujimoto H, Hirayama K, et al. Circulating soluble selectins in Kawasaki disease. Clin Exp Immunol 1997;108:446-50   DOI   PUBMED
10 Park CS, Suh CJ, Cho SH, Lee DB. Muco-cutaneous lymphnode syndrome : five cases report. J Korean Pediatr Soc 1973;16:61-7
11 Curtis N, Levin M. Superantigen disease. Res Adv Pross 1996;15:31-51
12 Lee KY, Park MY, Han JW, Lee HS, Choi J, Whang KT. An epidemiologic study of Kawasaki disease(1987-2000) :Incidence of coronary artery complication in the acute stage. J Korean Pediatr Soc 2002;45:783-9
13 Kim SK. Inflammatory markers in coronary artery disease. Korean Circ J 2001;31:617-9
14 Burns JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matubara T, et al. Kawasaki disease : A brief history. Pediatrics 2000;106:e27   DOI   PUBMED   ScienceOn
15 Harada K. Intravenous $\gamma$-globulin treatment in Kawasaki disease. Acta Pediatr Jpn 1991;33:805-10   DOI
16 Williams AF, Barclay AN. The immunoglobulin superfamily-domains for cell surface recognition. Annu Rev Immunol 1988;6:381-405   DOI   ScienceOn
17 Barnes PJ, Liew FY. Nitric oxide and asthma inflammation. Immunol Today 1995;16:128-30   DOI   ScienceOn
18 Osborn L. Leukocyte adhesion to endothelium in inflammation.Cell 1990;62:3-6   DOI   PUBMED   ScienceOn
19 Hamamichi Y, Ichida F, Yu X, Hirono KI, Uese KI, Hashimito I, et al. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease : its possible role in progression of coronary artery lesions. Pediatr Res 2001;49:74-80   DOI   ScienceOn
20 Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26   DOI   ScienceOn
21 Rader DJ. Inflammatory markers of coronary risk. N Engl J Med 2000;343:1179-82   DOI   ScienceOn
22 Park YW, Park IS, Kim CH, Ma JS, Lee SB, Kim CH, et al. Epidemiologic study of Kawasaki disease in Korea, 1997-1999 : Comparison with previous studies during 1991-1996. J Korean Med Sci 2002;17:453-6
23 Kato H, Ichinose E, Yoshioka F. Fate of coronary aneurysm in Kawasaki disease : serial coronary angiography and long-term follow-up study. Am J Cardiol 1982;49:1758-66   DOI   ScienceOn
24 Leung DYM. Superantigens related to Kawasaki syndrome. Springer Semin Immunopathol 1996;17:385-96
25 Levein M, Tizard EJ, Dillon MJ. Kawasaki disease : recent advanced. Arch Dis Child 1991;66:1369-72   DOI   ScienceOn
26 Zimerman GA, Prescott SM, McIntyre TM. Endotherial cell interactions with granulocytes : tethering and signaling molecules. Immunol Today 1992;13:93-100   DOI   ScienceOn
27 Jang YJ, Kim JG, Yun YS. The clinical observation in Kawasaki disease. J Korean Med Sci 1992;35:330-41
28 Yanagawa H, Nakamura Y, Yashiro M, Ojima T, Koyanagi H, Kawasaki T. Update of the epidemiology of Kawasaki disease in Japan - from the results of 1993-94 nationwide survey. J Epidemiol 1996;6:148-57   DOI   ScienceOn
29 Lin CY, Lin CC, Hwang B. Serial changes of IL-6, IL-8 and TNF-$\alpha$ among patients with Kawasaki disease. J Pediatr 1992;121:924-6   DOI   PUBMED
30 Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993;14:506-12   DOI   ScienceOn
31 Americian Heart Association. Diagnostic guidelines for Kawasaki disease. Circulation 2001;87:1776-80
32 Kurotobi S, Nagai T, Kawakami N, Sano T. Coronary diameter in normal infants, children and patients with Kawasaki disease. Pediatr Int 2002;44:1-4   DOI   ScienceOn
33 Hirose S, Hamashima Y. Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome. Eur J Pediatr 1978;129:17-27   DOI   ScienceOn
34 Leung DYM, Meissner C, Fluton D, Schlievert PM. The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome. J Clin Immunol 1995;15:11-7   DOI
35 Alzari PM, Lascombe MB, Poljak RJ. Three-dimensional structure of antibodies. Annu Rev Immunol 1988;6:555-80   DOI   ScienceOn
36 Rowley AH, Shulman ST. Kawasaki syndrome. Pediatr Clin North Am 1999;46:313-29   DOI   ScienceOn
37 Maury CP, Salo E, Pelkonen P. Circulating interleukin-1 beta in patients with Kawasaki disease. N Engl J Med 1988;319:1670-1   DOI   ScienceOn